Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-28

Clinical Trial Update: Very Low-Nicotine Cigarettes in Smokers With SUD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating very low-nicotine cigarettes in smokers with substance use disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Brown University | Conditions: Nicotine Dependence | Phase 2 | Status: COMPLETED